buprenorphine (Sublocade)

Original post, click here

Generic Name: buprenorphine

Brand Name: Sublocade

Manufacturer: Indivior Canada Ltd.

Indications: Opioid use disorder, treatment

Manufacturer Requested Reimbursement Criteria1:

For the treatment of moderate-to-severe opioid use disorder in adults. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support.

Submission Type: New

Project Status: Pending

Call For Patient Input: July 25, 2018

Patient Input Closed: September 14, 2018

Anticipated Date: August 23, 2018

Biosimilar: No

Fee Schedule: Pending

  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Submit Feedback


mental health, pain management